Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

CAR-T Meeting 2021 | Keynote lectures and BiTE vs CAR-T debate

Nicolaus Kröger • 27 Jan 2021
CAR-T Meeting 2021
Lymphoma Multiple Myeloma Antibodies BiTEs CAR-T

Nicolaus Kröger, MD, University Medical Center Hamburg, Hamburg, Germany, describes what he is looking forward to from the upcoming European CAR T-cell Meeting 2021, including the keynote lectures from world-renowned leaders in the field, who will present their most recent work and discuss the expected developments in the near future. Additionally, Prof. Kröger highlights the session comparing CAR T-cell therapy and bispecific T-cell engagers (BiTEs). This interview was recorded during an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Nicolaus Kröger

1:23
COSTEM 2023: congress highlights and importance
Nicolaus Kröger • 21 Oct 2023
0:35
The importance of bridging therapy in follicular and mantle cell lymphoma
Nicolaus Kröger • 28 Oct 2022
1:31
CAR-T therapy versus autoSCT in DLBCL
Nicolaus Kröger • 28 Oct 2022
0:51
The need for disease-modifying drugs in myelofibrosis
Nicolaus Kröger • 28 Oct 2022

Related Videos

1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
2:28
Checkpoint inhibitors vs brentuximab vedotin as salvage therapy prior to alloSCT for HL
Jacopo Mariotti • 15 Apr 2024
1:47
Looking forward to the Miami Myeloma MRD Virtual Meeting 2024
Ola Landgren • 13 Apr 2024
The content of VJHemOnc is intended for healthcare professionals